For laboratory research use only. Not for human or veterinary use. This is educational reference information, not medical advice.
ARA-290 · Cibinetide

ARA-290

Tissue-Derived Peptides
Overview
Scientific nameCibinetide
SynonymsPHBSP
AbbreviationARA-290
CAS Number1208243-50-8
Molecular formulaC51H84N16O21
Molecular weight1257.3 g/mol (average)
PubChem CID91810664
2D / 3D structure
2D chemical structure of ARA-290
Research Summary

Mechanisms under investigation

The following are areas of ongoing preclinical investigation. They describe hypotheses and observations reported in the literature, not established clinical effects.

Evidence tiers below reflect how much has been studied in each model type. Counts describe research volume — they do not indicate proven efficacy, safety, or clinical consensus.

Evidence base (transparent counts)

Cellular studies 0 publications
Animal studies 2 publications
Human observational reports 0 publications
Controlled human trials 0 publications
Review articles 0 publications
Publication Library

Selected literature

Filter by study model. Each record is classified for the evidence base above.

2018
Preclinical study examining cibinetide signaling through the EPOR-beta common receptor complex and wound closure outcomes in genetically diabetic mice.Animal · mouse · PubMed (29223734)
2017
Preclinical study reporting effects of cibinetide on innate immune cell function and disease course in an experimental colitis model.Animal · PubMed (29026145)

Each record maps to a structured evidence row with study model, species, and support level.

Laboratory Information

Handling and reference

Molecular weight calculator

Average-mass estimate from a one-letter sequence.

Reconstitution calculator

Laboratory concentration only. Not dosing guidance.

Frequently Asked Questions
What is ARA-290?
ARA-290 is a research compound; the identity and structure data shown here are compiled from public chemical databases (primarily PubChem). For laboratory research use only.
What research models has it been studied in?
The literature indexed here is predominantly cellular (in vitro) and animal studies. See the evidence base and publication library above for the transparent counts by study model.
Is there controlled human clinical trial evidence?
Controlled human clinical trials are counted separately in the evidence base above. Cellular and animal findings do not establish human clinical effects.
How is it stored and handled in a laboratory?
Refer to the laboratory information section above.
Is this intended for human use?
No. All information and materials are for laboratory research use only — not for human or veterinary use, and not intended to diagnose, treat, cure, or prevent any disease.
Documentation

Research material & documentation

This profile is an educational reference. Lot-level laboratory documentation for materials supplied by Peptide Titans is published openly.

ARA-290 research material →  ·  Lot-specific Certificates of Analysis →  ·  How lots are tested →

References and Citation

Evidence records

  1. Preclinical study examining cibinetide signaling through the EPOR-beta common receptor complex and wound closure outcomes in genetically diabetic mice. (2018) — in vivo — PubMed.
  2. Preclinical study reporting effects of cibinetide on innate immune cell function and disease course in an experimental colitis model. (2017) — in vivo — PubMed.

Every record carries a study model, species, support level and review status in the evidence table. Terms used throughout these profiles are defined in the peptide research glossary.

Citation generator

Loading citation...

Explore the full research database

Browse peptide profiles, publications, and laboratory references — all research-only.

For laboratory research use only. Not for human or veterinary use. Educational reference information — not medical advice.